300+ investors in your industry, stage, and region Get
Any industry
Community
Proptech
Biotech
Climate
Artificial Intelligence
Media (Entertainment)
Impact
FinTech
Marketplace
EdTech
Consumer
Agriculture (AgTech)
Web3
Clean Energy
B2B
Organic Food
Big Data
Video Games
Payments
Celebrity
Franchise
Mobile
Local
Social Network
Platforms
Crowdfunding
CleanTech
Film
Theatre
Life Science
Non Profit
Transportation
Gaming
Energy
Hardware
Health Care
Enterprise
Sustainability
Venture Capital
Restaurants
Fashion
Real Estate
Retail
Infrastructure
Mobile Apps
Beauty
LGBT
Publishing
Sporting Goods
Oil and Gas
Education
Renewable Energy
Food and Beverage
Cryptocurrency
Finance
Financial Services
Photography
Art
Medical
Digital Media
Music
Internet
Social Media
Manufacturing
Facebook
Blockchain
Legal
Android
Social Impact
Google
Construction
Sports
eSports
Enterprise Software
Email
Wellness
Hospitality
Travel
Fitness
Mobile Advertising
Cannabis
Recruiting
Biotechnology
Medical Device
Wine and Spirits
Automotive
Social
InsurTech
SaaS
Software
Any country
Qatar
South Korea
Africa
Asia
LATAM
Europe
Oceania
Middle East
Ireland
Singapore
Indonesia
Spain
Saudi Arabia
Belarus
Belgium
Colombia
Denmark
Ecuador
Czech Republic
Estonia
Ghana
Ethiopia
Finland
Barbados
Italy
Jersey
Cayman Islands
Mali
Malaysia
Mauritius
Poland
Rwanda
Togo
Slovenia
San Marino
Tanzania
Thailand
Uruguay
Venezuela
Portugal
Azerbaijan
Namibia
Bolivia
Latvia
Cyprus
New Zealand
United States
Germany
Australia
India
United Kingdom
Canada
China
South Africa
Brazil
Japan
Sri Lanka
Vietnam
Argentina
Armenia
Austria
Bangladesh
Bahrain
Bulgaria
Bermuda
Chile
Cameroon
Switzerland
Belize
Costa Rica
Algeria
Georgia
Egypt
Hong Kong
Gibraltar
Faroe Islands
Greece
Croatia
France
Hungary
Kuwait
Israel
Lebanon
Cambodia
Kenya
Jordan
Lithuania
Liberia
Liechtenstein
Myanmar
Kazakhstan
Morocco
Norway
Mexico
Panama
Malta
Peru
Philippines
Nicaragua
Pakistan
Russian Federation
Romania
Sweden
Serbia
Seychelles
Turkey
Puerto Rico
Sierra Leone
Senegal
Tunisia
Tajikistan
El Salvador
Uganda
Zambia
Uzbekistan
Taiwan
Ukraine
Zimbabwe
Bahamas
Guatemala
Iraq
Iceland
Nigeria
United Arab Emirates
Honduras
Isle of Man
Luxembourg
Oman
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Health Care VC Funds & Investors in Europe (October 2023)

The most active venture capital funds investing in Europe Health Care startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Europe Health Care startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Bpifrance
VC Fund
88 France, United States, Switzerland Seed, Series A Software, Health Care, Information Technology $643k–$29M
High-Tech Grunderfonds
VC Fund
67 Germany, Switzerland, United States Seed, Series A Software, Information Technology, Biotechnology $665k–$16M
Enterprise Ireland
VC Fund
62 Ireland, United States, United Kingdom Seed, Series A Software, Health Care, Information Technology $429k–$12M
UK Innovation & Science Seed Fund
VC Fund
54 United Kingdom, United States Seed, Series A Biotechnology, Health Care, Medical $246k–$10M
Sofinnova Partners
VC Fund
53 France, United States, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $4.4M–$57M
Parkwalk Advisors
VC Fund
51 United Kingdom, United States, Philippines Seed, Series A, Series B Biotechnology, Health Care, Software $860k–$33M
Kurma Partners
VC Fund
48 France, Spain, Switzerland Series A, Seed, Series B Health Care, Biotechnology, Medical $2.1M–$80M
Deepbridge Capital
VC Fund
43 United Kingdom, Australia, Singapore Seed, Series A Health Care, Biotechnology, Medical $143k–$10M
Oxford Technology Management
VC Fund
43 United Kingdom, United States Seed, Series A Biotechnology, Health Care, Software $25k–$7.4M
Mercia Fund Managers
VC Fund
41 United Kingdom, United States, Hungary Seed, Series A Software, Health Care, Biotechnology $184k–$21M
Oxford Science Enterprises
VC Fund
40 United Kingdom, United States, The Netherlands Seed, Series A Biotechnology, Health Care, Software $1M–$34M
Scottish Investment Bank
VC Fund
40 United Kingdom, United States, France Seed, Series A Software, Biotechnology, Information Technology $307k–$7.6M
Development Bank of Wales
VC Fund
40 United Kingdom, Australia, United States Seed, Debt Financing Health Care, Software, Biotechnology $12k–$2.8M
Scottish Enterprise
VC Fund
39 United Kingdom, United States, Japan Grant, Seed Biotechnology, Software, Health Care $92k–$4.1M
Calm/Storm Ventures
VC Fund
38 United Kingdom, Germany, Austria Seed, Pre-Seed, Series A Health Care, Wellness, Medical $436k–$5.4M
AlbionVC
VC Fund
37 United Kingdom, United States, France Series A, Seed Software, Health Care, Artificial Intelligence $1.8M–$13M
Catapult Ventures
VC Fund
34 United Kingdom, United States, Israel Seed, Series A Health Care, Biotechnology, Pharmaceutical $123k–$26M
Seventure Partners
VC Fund
33 France, United States, Germany Series A, Series B Biotechnology, Health Care, Software $2.4M–$35M
Almi Invest
VC Fund
32 Sweden, United States, United Kingdom Seed, Pre-Seed Software, Health Care, Information Technology $96k–$1.8M
Karista
VC Fund
32 France, United States, Norway Seed, Series A, Series B Software, Biotechnology, Health Care $321k–$32M
Novo Holdings
VC Fund
32 United States, Denmark, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $6.5M–$125M
IBB Ventures
VC Fund
32 Germany, United States, United Kingdom Seed, Series A Software, Health Care, Internet $820k–$7M
Oxford Capital
VC Fund
30 United Kingdom, United States, France Seed, Series A Software, Mobile, Health Care $1.6M–$13M
Newable Private Investing
VC Fund
30 United Kingdom, United States Seed, Series A Software, Health Care, Biotechnology $184k–$3.8M
Idinvest Partners
VC Fund
29 France, United States, Spain Series B, Series A Biotechnology, Software, Health Care $3.2M–$53M
Atlantic Labs
VC Fund
29 Germany, Switzerland, United States Seed, Series A, Pre-Seed Health Care, Software, Information Technology $850k–$27M
SyndicateRoom
VC Fund
28 United Kingdom, United States, India Seed, Equity Crowdfunding Health Care, Software, Medical $229k–$1.8M
Cambridge Angels group
VC Fund
28 United Kingdom, United States, Estonia Seed, Series A Software, Health Care, Biotechnology $244k–$16M
Speedinvest
VC Fund
26 Germany, United Kingdom, Austria Seed, Series A, Pre-Seed Software, FinTech, Financial Services $396k–$50M
Business Growth Fund
VC Fund
26 United Kingdom, Ireland, United States Series A, Private Equity Software, Information Technology, Manufacturing $1.2M–$28M
IP Group
VC Fund
25 United Kingdom, United States, Australia Seed, Series A, Series B Health Care, Biotechnology, Therapeutics $369k–$61M
Omnes Capital
VC Fund
24 France, United States, Belgium Series A, Series B Software, Biotechnology, Health Care $3.2M–$37M
GO CAPITAL
VC Fund
24 France, Canada, Israel Seed, Series A Biotechnology, Software, Health Care $504k–$6.4M
Nina Capital
VC Fund
24 United States, United Kingdom, Austria Seed, Pre-Seed, Series A Health Care, Artificial Intelligence, Medical $573k–$21M
GM&C Life Sciences Fund
VC Fund
24 United Kingdom, Italy, Germany Seed, Series A Health Care, Biotechnology, Medical $61k–$903k
Sciety
VC Fund
24 Sweden, Ukraine Seed, Series A Health Care, Biotechnology, Pharmaceutical $125k–$6.1M
24 Haymarket
VC Fund
23 United Kingdom, United States Seed, Series A Health Care, Software, Information Technology $1.2M–$16M
Kelvin Capital
VC Fund
23 United Kingdom, United States Seed, Series A Health Care, Biotechnology, Manufacturing $139k–$24M
Boehringer Ingelheim Venture Fund
VC Fund
23 United States, Germany, Belgium Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $1.3M–$50M
Octopus Ventures
VC Fund
22 United Kingdom, United States, Germany Series A, Seed, Series B Software, Health Care, FinTech $1.2M–$45M
Auriga Partners
VC Fund
22 France, United States, Switzerland Series B, Series A Biotechnology, Health Care, Medical $2.1M–$31M
Bayern Kapital
VC Fund
22 Germany, United States, Finland Seed, Series A Software, Information Technology, Health Care $750k–$16M
Think.Health
VC Fund
22 Germany, United States, Switzerland Seed, Series A, Series B Health Care, Biotechnology, Medical Device $1.1M–$19M
Kernel Capital
VC Fund
22 Ireland, United Kingdom, France Seed, Series A Software, Information Technology, Health Care $536k–$9M
Archangels
VC Fund
22 United Kingdom, United States Seed, Series A Software, Biotechnology, Health Care $123k–$7M
Meusinvest (Noshaq)
VC Fund
22 Belgium, France, Germany Seed, Series A Health Care, Biotechnology, Medical $134k–$15M
Portugal Ventures
VC Fund
22 Portugal, United States, France Seed, Pre-Seed Software, Health Care, Information Technology $107k–$1.6M
M Ventures
VC Fund
22 United States, Switzerland, United Kingdom Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $2.1M–$67M
Northstar Ventures
VC Fund
22 United Kingdom, United States, Estonia Seed, Series A Software, E-Commerce, Internet $37k–$8.8M
Epidarex Capital
VC Fund
21 United Kingdom, United States, Germany Series A, Seed, Series B Biotechnology, Therapeutics, Health Care $536k–$38M
Access all 50 VC funds in Europe Health Care startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Bpifrance
VC Fund · Maisons-alfort, Ile-de-France, France · 88 investments in Europe Health Care startups, 117 in the past 12 months

Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.Bpifrance was founded in 2012 and is based in Maisons-alfort, Ile-de-France,France.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Seed, Series A
  • Geography: France, United States, Switzerland

Investor stats

  • Total investments: 667
  • Round size: Seed $643k–$5.4M; Series A $2M–$29M
  • Lead/follow: 22% lead, 78% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • Nonna Lab — Make the Most. Le laboratoire qui vous rend la vie meilleure.
  • Altior — Altior is an IT company that offers cloud industrial management software and ERP solution.
  • Umiami — Umiami Technologies is a leader in plant-based meat. Our proprietary technology allows us to create clean-label and incredibly tasty foods.
Show all investments...

High-Tech Grunderfonds
VC Fund · Bonn, Nordrhein-Westfalen, Germany · 67 investments in Europe Health Care startups, 64 in the past 12 months

High-Tech Gründerfonds (HTGF) is a seed investor that finances high-potential, tech-driven startups. With EUR 895.5 million in total investment volume across three funds and an international network of partners, HTGF has already helped forge more than 500 startups since 2005. Driven by their expertise, entrepreneurial spirit, and passion, its teamof experienced investment managers and startup experts help guide the development of young companies. HTGF’s focus is on high-tech startups in a range of sectors, including software, media, internet, hardware, automation, health care, chemistry, and life sciences.To date, external investors have injected over EUR 2 billion into the HTGF portfolio via about 1,400 follow-on financing rounds. HTGF has also successfully sold interests in more than 100 companies. Investors in this public-private partnership include the Federal Ministry For Economic Affairs and Energy, the KfW Banking Group, and Fraunhofer-Gesellschaft e.V., as well as the companies ALTANA, BASF, BAYER, B.Braun, Boehringer Ingelheim, Robert Bosch, BÜFA, CEWE, Deutsche Post DHL, Dräger, Drillisch AG, EVONIK, EWE AG, FOND OF Haniel, Hettich, Knauf, Körber, LANXESS, media + more venture Beteiligungs GmbH & Co. KG, PHOENIX CONTACT, Postbank, QIAGEN, RWE Generation SE, SAP, Schufa, Schwarz Gruppe, STIHL, Thüga, Vector Informatik, WACKER and Wilh. Werhahn KG.

Show more...

Investment focus

  • Industry: Software, Information Technology, Biotechnology
  • Stage:Seed, Series A
  • Geography: Germany, Switzerland, United States

Investor stats

  • Total investments: 373
  • Round size: Seed $665k–$5.1M; Series A $1.5M–$16M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Inovedis — Inovedis offers innovative solutions in medical technology that contribute both to optimized patient care as well as time and cost reductions in the healthcare sector.
  • Resourcify — Mein Recycling is developed by Resourcify GmbH from Hamburg. The app is the easiest solution for businesses to easily manage all of their waste, collections, and recyclers in one app, and for waste management companies to seamlessly connect with their customers online. Their vision is zero-waste: enabled with the digital transformation of the wastesector as the foundation for the circular economy.
  • traceless materials — traceless materials offer a holistically sustainable alternative to plastics: 100% biobased on plant residues, compostable under natural conditions, and free of toxic chemicals. For a future free of pollution and waste!
Show all investments...

Enterprise Ireland
VC Fund · Dublin, Dublin, Ireland · 62 investments in Europe Health Care startups, 19 in the past 12 months

Enterprise Ireland is the government agency responsible for the development and funding of the indigenous business sector. Their mission is to accelerate the development of companies to achieve strong positions in global markets resulting in increased national and regional prosperity. It was founded in 1998 and headquartered in Dublin, Ireland.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Seed, Series A
  • Geography: Ireland, United States, United Kingdom

Investor stats

  • Total investments: 383
  • Round size: Seed $429k–$2.9M; Series A $2M–$12M
  • Lead/follow: 15% lead, 85% follow
  • Last fund: May invest from a new fund soon — raised $1.1M in 2021

Portfolio highlights

  • CergenX — CergenX produces cutting-edge technology for the analysis of baby brain waves that can be used to identify brain injuries early in the newborn period.
  • Tailr — Redefining production for the clothing industry.
  • Recruitroo — Recruitroo is a international recruitment agency that uses technologies to streamline and improve the international recruitment process for both companies and candidates.
Show all investments...

UK Innovation & Science Seed Fund
VC Fund · Harwell, Oxfordshire, United Kingdom · 54 investments in Europe Health Care startups, 13 in the past 12 months

UKI2S, formally the Rainbow Seed Fund, is an investment fund backed by the government, providing seed funding to science & technology start-ups and SMEs

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 96
  • Round size: Seed $246k–$2.9M; Series A $2.7M–$10M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: May invest from a new fund soon — last raise in 2014

Portfolio highlights

  • Machine Discovery — Machine Discovery is a University of Oxford spin-out commercializing new machine learning technology. We leverage proprietary neural network technology to accelerate expensive calculations — and we do it with minimal data and 99.9% fidelity.
  • Pencil Biosciences — Next Generation Genome Editing Tool
  • Laverock Therapeutics — Laverock Therapeutics is developing a gene silencing platform for the creation of programmable, allogeneic cell therapies.
Show all investments...

Sofinnova Partners
VC Fund · Paris, Ile-de-France, France · 53 investments in Europe Health Care startups, 21 in the past 12 months

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 232
  • Round size: Series A $4.4M–$53M; Series B $7M–$57M; Series C $10M–$54M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
  • Sitryx Therapeutics — Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism.Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at multiple stages of drug discovery. Sitryx is headquartered in Oxford, UK.
  • Tenpoint Therapeutics — Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.
Show all investments...

Parkwalk Advisors
VC Fund · London, England, United Kingdom · 51 investments in Europe Health Care startups, 12 in the past 12 months

Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009,anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth.Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Philippines

Investor stats

  • Total investments: 211
  • Round size: Seed $860k–$3.7M; Series A $1.5M–$12M; Series B $1.8M–$33M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • RoboK — A Cambridge University spin-out building cost-effective 3D sensing software technology
  • Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
  • PharmEnable — Designing the next generation of small molecule drugs. Replicating the specificity of biologics in the scalable form of a small molecule.
Show all investments...

Kurma Partners
VC Fund · Paris, Ile-de-France, France · 48 investments in Europe Health Care startups

Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Seed, Series B
  • Geography: France, Spain, Switzerland

Investor stats

  • Total investments: 95
  • Round size: Seed $2.1M–$7.5M; Series A $2.1M–$50M; Series B $4.1M–$80M
  • Lead/follow: 53% lead, 47% follow
  • Last fund: May invest from a new fund soon — raised $89M in 2020

Portfolio highlights

  • Xeltis — Xeltis is pioneering a restorative approach in cardiovascular therapy.
  • Axithra — Saving lives and improving health economics through significant advancement of therapeutic drug monitoring (TDM).
  • Kiro — Kiro is an IT company that offers artificial intelligence, ergonomic design, and software development solutions for medical biology.
Show all investments...

Deepbridge Capital
VC Fund · Chester, Cheshire, United Kingdom · 43 investments in Europe Health Care startups

Deepbridge is a different kind of investment manager. They work closely with financial advisers and investors to design innovative products, ranging from investment in technology growth companies to asset-backed renewable energy projects. They also partner with innovative and committed management teams to help UK based companies realise theirpotential and become successful leading-edge businesses.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: United Kingdom, Australia, Singapore

Investor stats

  • Total investments: 77
  • Round size: Seed $143k–$2.1M; Series A $1.8M–$10M
  • Lead/follow: 78% lead, 22% follow
  • Last fund: Likely still investing — raised $1.2M in 2022

Portfolio highlights

  • Circada — Innovative Circadian lighting reconnects the body clock with nature
  • Microplate Dx — Microplate Dx is a developer of diagnostic technology aimed at significantly reducing fatalities caused by drug-resistant infections.Microplate Dx, an award-winning spinout company from the University of Strathclyde in Glasgow, focuses on creating innovative diagnostic solutions to combat the significant global health challenge of antimicrobialresistance. Their technology revolves around the ingenious concept of employing highly sensitive biosensor electrodes, enhanced with miniaturized hydrogel deposits containing various antibiotics tailored to the specific infection being detected. The primary mission of Microplate DX is to proactively prevent and manage the proliferation of antimicrobial resistance on a global scale.
  • GenoMe Diagnostics — GenoME Diagnostics - We are developing a blood test for an earlier and more accurate diagnosis of ovarian cancer.GenoME Diagnostics .
Show all investments...

Oxford Technology Management
VC Fund · Oxford, Oxfordshire, United Kingdom · 43 investments in Europe Health Care startups

Oxford Technology's SEIS fund and EIS fund enable private investors to access high growth technology startup opportunities and support UK innovation. SEIS and EIS tax reliefs offer downside protection, whilst gains can be tax free.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 104
  • Round size: Seed $25k–$2M; Series A $737k–$7.4M
  • Lead/follow: 7% lead, 93% follow
  • Last fund: May invest from a new fund soon — last raise in 2012

Portfolio highlights

  • OxCan — Enabling curative cancer treatment through early detection
  • Machine Discovery — Machine Discovery is a University of Oxford spin-out commercializing new machine learning technology. We leverage proprietary neural network technology to accelerate expensive calculations — and we do it with minimal data and 99.9% fidelity.
  • MitoRx Therapeutics — Developing revolutionary mitochondrial-protective therapeutics which reverse mitochondrial dysfunction to arrest decline in muscular dystrophy and neurodegeneration. MitoRx Therapeutics' first-in-class first-in-target platform has potential to arrest the progression of some of the most challenging diseases.
Show all investments...

Mercia Fund Managers
VC Fund · Henley In Arden, Warwickshire, United Kingdom · 41 investments in Europe Health Care startups, 8 in the past 12 months

Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Hungary

Investor stats

  • Total investments: 119
  • Round size: Seed $184k–$1.8M; Series A $1.2M–$21M
  • Lead/follow: 69% lead, 31% follow
  • Last fund: May invest from a new fund soon — last raise in 2013

Portfolio highlights

  • CanSense — CanSense is a developer of an inexpensive and scalable blood test intended for early diagnosis of bowel cancer.
  • Workbuzz — Issue employee engagement surveys with WorkBuzz - a fast, simple, and flexible platform with expert consultancy. Try it now!
  • Centuro Global — Centuro Global helps you go global.We help startups, scaleups & corporates enter new markets around the world. All your international expansion needs are serviced from one platform, whether you need legal support, tax & accounting, HR, opening a bank account or finding office space, we can assist across the board.Our innovativeplatform, Centuro Connect, contains blueprints on how to do business in over 150 countries, provides live chat advice, and access to local experts around the world. Instead of losing time undertaking Google searches for relevant information and identifying trusted, cost-effective service providers, find all your solutions through Centuro Connect.Come to us for services including; Legal, Immigration, Intellectual Property, Scaling & Expansion, New Market Entry, Tax & Accounting and much more.Receive advice, find service providers, investors and like minded individuals, and seamlessly grow your business.Book a free consultation with us: www.centuroglobal.com
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Oxford Science Enterprises
VC Fund · Oxford, Oxfordshire, United Kingdom · 40 investments in Europe Health Care startups, 15 in the past 12 months

Oxford Sciences Innovation is the world’s largest university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companiestaking on challenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, The Netherlands

Investor stats

  • Total investments: 123
  • Round size: Seed $1M–$6.8M; Series A $3.7M–$34M
  • Lead/follow: 41% lead, 59% follow

Portfolio highlights

  • Navenio — Navenio is a software technology company that provides location-based services for indoor environments via mobile applications. Its solution provides an improvement on other indoor localization technologies, having the ability to locate people without the need for implementing, managing, or surveying any new building hardware such as beacons orwi-fi. Navenio’s intelligent workforce solution unlocks significant improvements in the efficiency and workflow of staff and teams through automation that is carefully driven from real-world best practice.The company was founded in 2015 and is headquartered in Oxford, England.
  • AlveoGene — Welcome to AlveoGene Transforming Rare Respiratory Disease Outcomes Using Inhaled Gene Therapy More information
  • Sitryx Therapeutics — Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism.Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at multiple stages of drug discovery. Sitryx is headquartered in Oxford, UK.
Show all investments...

Scottish Investment Bank
VC Fund · Glasgow, Glasgow City, United Kingdom · 40 investments in Europe Health Care startups

Our Entrepreneurship team (formerly the Scottish Investment Bank) helps you find sources of finance, engage with funders and secure investment to grow your business.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, France

Investor stats

  • Total investments: 195
  • Round size: Seed $307k–$2.5M; Series A $1.5M–$7.6M
  • Lead/follow: 10% lead, 90% follow
  • Last fund: May invest from a new fund soon — last raise in 2015

Portfolio highlights

  • Bio-Images Drug Delivery — BDD Pharma combine drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and new innovative pharmaceutical products. Rapid parallel clinical testing with SWIFT significantly reduces time from product concept to clinical success.
  • IOTech — Discover IOTech Systems, the open edge data platform for developing, deploying, and managing Industrial Edge applications at scale. Find out more here.
  • Administrate — Manage 100% of enterprise training operations with configurable training management software, designed to scale with your organization.
Show all investments...

Development Bank of Wales
VC Fund · Cardiff, Cardiff, United Kingdom · 40 investments in Europe Health Care startups, 11 in the past 12 months

Development Bank of Wales is formed in 2001 by the Welsh Assembly Government. Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.

Show more...

Investment focus

  • Industry: Health Care, Software, Biotechnology
  • Stage:Seed, Debt Financing
  • Geography: United Kingdom, Australia, United States

Investor stats

  • Total investments: 149
  • Round size: Seed $307k–$1.8M; Debt Financing $12k–$2.8M
  • Lead/follow: 58% lead, 42% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • CanSense — CanSense is a developer of an inexpensive and scalable blood test intended for early diagnosis of bowel cancer.
  • Stratigens — Talent intelligence software| external people analytics | Diversity, location planning and skills data to inform strategy | Data based decision making
  • 2B Enterprising — 2B Enterprising offers an enterprise education program for primary schools that aims to inspire next generation and foster an entrepreneurial mindset.
Show all investments...

Scottish Enterprise
VC Fund · Glasgow, Glasgow City, United Kingdom · 39 investments in Europe Health Care startups, 24 in the past 12 months

Scotland's business advice, support and funding agency. Explore our products and services to find the right support for your business and apply online today.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Grant, Seed
  • Geography: United Kingdom, United States, Japan

Investor stats

  • Total investments: 193
  • Round size: Seed $197k–$2.9M; Grant $92k–$4.1M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • Pneumagen — Pneumagen focuses on developing glycan targeted carbohydrate-binding modules (CBMs) as a new universal therapeutic modality for the treatment of respiratory tract infections (RTIs) and cancer. Founded in 2016, the Company is a spin-out from the University of St Andrews in Scotland and has access to world-class scientific expertise and capabilitiesin glycobiology.
  • Microplate Dx — Microplate Dx is a developer of diagnostic technology aimed at significantly reducing fatalities caused by drug-resistant infections.Microplate Dx, an award-winning spinout company from the University of Strathclyde in Glasgow, focuses on creating innovative diagnostic solutions to combat the significant global health challenge of antimicrobialresistance. Their technology revolves around the ingenious concept of employing highly sensitive biosensor electrodes, enhanced with miniaturized hydrogel deposits containing various antibiotics tailored to the specific infection being detected. The primary mission of Microplate DX is to proactively prevent and manage the proliferation of antimicrobial resistance on a global scale.
  • Rapscallion Soda — Award Winning, Fresh Fruit, Low Calorie Soft Drinks, Handmade in Scotland. Fresh batches made weekly. Free UK Mainland Delivery. International Shipping. Ginga Ninja | Burnt Lemon | Dry Lime | Scottish Rhubarb Soda | Scottish Strawberry Soda | Cranachan Soda | Blueberry Soda Love soda. Hate hangovers. Drink local.
Show all investments...

Calm/Storm Ventures
VC Fund · Vienna, Wien, Austria · 38 investments in Europe Health Care startups, 21 in the past 12 months

Calm/Storm is an exclusive founder network and venture capital firm. We invest in purpose driven founders changing our life & health for the better. Headquartered in Vienna, Austria we invest in early-stage companies all over Europe and the US. We focus on the pre-seed and seed stages but also invest up to Series A.

Show more...

Investment focus

  • Industry: Health Care, Wellness, Medical
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, Germany, Austria

Investor stats

  • Total investments: 65
  • Round size: Seed $1.2M–$5.4M; Pre-Seed $436k–$2.7M
  • Lead/follow: 12% lead, 88% follow
  • Last fund: May invest from a new fund soon — raised $21M in 2020

Portfolio highlights

  • thymia — Making mental health as objectively measurable as physical health.
  • Bea Fertility — Bea Fertility is a monthly subscription program that provides users with at-home fertility treatment and ovulation tracking.
  • Lindus Health — Lindus Health. From recruitment to delivery, we accelerate clinical trials. Our mission is to make health research accessible for everyone, everywhere.
Show all investments...

AlbionVC
VC Fund · London, England, United Kingdom · 37 investments in Europe Health Care startups, 9 in the past 12 months

AlbionVC supports visionary founders with long-term capital and scale-up expertise, and manages c. $1 billion of venture funds, invested in 50+ companies. AlbionVC is the technology investment arm of Albion Capital Group LLP. The technology team invest from seed through to Series B in high growth companies, predominantly in the UK. The team has a focus on B2B software and technology enabled services. AlbionVC %

Show more...

Investment focus

  • Industry: Software, Health Care, Artificial Intelligence
  • Stage:Series A, Seed
  • Geography: United Kingdom, United States, France

Investor stats

  • Total investments: 119
  • Round size: Seed $1.8M–$13M; Series A $3.2M–$12M
  • Lead/follow: 39% lead, 61% follow

Portfolio highlights

  • Umedeor — uMed is a technology platform embedded across a global network of healthcare providers that automates the process of building prospective, protocolized patient registries. This enables sites to participate in dozens of programmes simultaneously without increasing overhead or burden on staff. For life science companies, uMed provides access toregulator quality data, where patients within those datasets can be compliantly re-engaged to support the aims of R&D and post-market teams
  • tem. — In a few simple steps we can manage your renewable energy needs forever.
  • Ramp Growth — How many users will your mobile game acquire, and how much more will they pour into your virtual economy? Try Ramp to find out.
Show all investments...

Catapult Ventures
VC Fund · Leicester, Leicester, United Kingdom · 34 investments in Europe Health Care startups

The team behind Catapult Ventures are among the most experienced venture capital investors in the UK.Their experience spans a range of sectors from healthcare and pharmaceuticals to luxury consumer brands, manufacturing and software, as well as all stages: from start-ups and pre-revenue IP developers to company floatation and billions of poundsin revenue. Their administration team is equally experienced with each member having more than 10 years experience in a venture capital environment.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Pharmaceutical
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Israel

Investor stats

  • Total investments: 96
  • Round size: Seed $123k–$985k; Series A $1.6M–$26M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • Pickle Robot — We make robots that unload trucks without retrofitting the warehouse
  • Urban Machine — Salvaging the past to build the future- Stealth Startup
  • Pencil Biosciences — Next Generation Genome Editing Tool
Show all investments...

Seventure Partners
VC Fund · Paris, Ile-de-France, France · 33 investments in Europe Health Care startups, 7 in the past 12 months

Seventure Partners is a French venture capital firm targeting in information and communication technology, and life sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with€ 660 million under management as of December 31, 2016. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series A, Series B
  • Geography: France, United States, Germany

Investor stats

  • Total investments: 175
  • Round size: Series A $2.4M–$18M; Series B $3M–$35M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Sinay — Use the full potential of your data with intelligent solutions. Become more efficient on a daily basis and reduce your environmental impact.
  • Allozymes — Allozymes, Pte. Ltd. is a leading deep technology company applying innovative ultrahigh-throughput microfluidics technology to accelerate enzyme evolution and development. We developed sensitive, accurate, and generic assays for the detection of enzymatic reactions, proprietary microfluidic chips and proteomics technologies to take enzymedevelopment to the next level.
  • Vedanta Biosciences — Vedanta Biosciences is a developer of immunotherapies designed to treat immune-mediated and infectious diseases. The company's immunotherapies include a suite of proprietary assays to select pharmacologically potent strains, vast proprietary datasets from human interventional studies, and facilities for cGMP-compliant manufacturing ofrationally-defined bacterial consortia in powder form, enabling physicians to access live bacteria drug to treat autoimmune and inflammatory diseases easily.It was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Show all investments...

Almi Invest
VC Fund · Stockholm, Stockholms Lan, Sweden · 32 investments in Europe Health Care startups, 11 in the past 12 months

ALMI Invest is a venture capital company which invests in Swedish companies with exciting, scalable business models and motivated entrepreneurs. ALMI Invest consists of eight regionally based venture capital funds, all with local offices and experienced local investment managers. We manage a total of SEK 1 billion. Unlike most venture capitalists,we can invest in a wide range of businesses. A strong team of entrepreneurs, a scalable business model and an initial revenue stream are more important than the line of business when we invest.Our first, initial investment would typically be SEK 2-4 million. During the lifetime of an investment, sums of up to SEK 10 million can be ventured. We always syndicate with an investment partner (another venture capitalist or angel investor) from Sweden or otherwise which means that we can take a maximum of 50 percent of an investment round.ALMI Invest was founded in 2009 by ALMI Fretagspartner together with regional investors. Half of our capital comes from European Union structural funds, which accounts for an investment of SEK 500 million. The other 50 per cent comes from regional investors and ALMI Fretagspartner.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Seed, Pre-Seed
  • Geography: Sweden, United States, United Kingdom

Investor stats

  • Total investments: 190
  • Round size: Seed $138k–$1.3M; Pre-Seed $96k–$1.8M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • Dicot — Dicot is a pharmaceutical company focused on drug discovery and the development of novel lifestyle drugs to enrich patients' lives. The Company develops and manufactures medicines for the treatment of erectile dysfunction and premature ejaculation. The company's lead candidate, LIB-01, is in the pre-clinical stage of development.
  • EmbeDL — Efficient Deep Learning for Embedded Systems
  • Nordic Forestry Automation — The forestry sector is standing before unprecedented challenges in adapting to increased demand for sustainable raw materials, carbon storage, biodiversity conservation and a shortage of highly skilled machine operators. Digital tools, precision forestry and automation will play a crucial role in
Show all investments...

Karista
VC Fund · Paris, Ile-de-France, France · 32 investments in Europe Health Care startups

Karista is an early-stage venture capital firm created in 2001 investing in Health, Digital, Tech, and NewSpace.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: France, United States, Norway

Investor stats

  • Total investments: 129
  • Round size: Seed $321k–$2.8M; Series A $1.1M–$4.3M; Series B $2.5M–$32M
  • Lead/follow: 12% lead, 88% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • Bfore.AI — Starting from patented technology developed in years of research, BforeAi is the prediction service that looks for newly registered or morphed domains, and score their maliciousness looking at metadata and links to other bad guys.
  • Exotrail — Exotrail is an end-to-end space mobility operator. Our mission is to enable small satellites to move in space, optimise their deployment, increase their service performance, and reduce space pollution.
  • Look Up Space — Lookup space is the next global leader for space safety, security and sustainability
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Novo Holdings
VC Fund · Hellerup, Hovedstaden, Denmark · 32 investments in Europe Health Care startups, 19 in the past 12 months

Novo Holdings is a world-leading life science investor with a focus on creating long-term value.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Denmark, United Kingdom

Investor stats

  • Total investments: 225
  • Round size: Series A $6.5M–$63M; Series B $12M–$125M; Series C $12M–$105M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • Octave — Octave is a national behavioral health practice that’s creating a new standard for care delivery that’s both high-quality and accessible to more people. With in-person and virtual clinics in California and New York, the company offers personalized care plans that can include individual therapy, couples therapy, and groups, while pioneeringrelationships with payers to make care more affordable through insurance. Grounded in science, Octave enables clients to experience profound change that is as measurable as it is meaningful.
  • Acesion Pharma — Acesion Pharma ApS is a Danish biotech company founded in 2011 and based in Copenhagen. Acesion Pharma develops more efficacious and safe drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia.
  • Alentis Therapeutics — Alentis Therapeutics discovers and develops novel medications to treat advanced liver diseases.
Show all investments...

IBB Ventures
VC Fund · Berlin, Berlin, Germany · 32 investments in Europe Health Care startups, 10 in the past 12 months

IBB Ventures is a venture capital and mezzanine arm of Investitionsbank Berlin specializing in seed/startup, early venture, and mid venture investments. The firm invests in technology-oriented companies and companies from the creative industries. It typically invests in information and communication sector with a focus on hardware andsoftware, network technology, new media, and internet and mobile technologies; life science sector with a focus on biotechnology and media technology; and industrial technologies sector with a focus on software, PPS, supply chain management, micro and nanotechnology, environmental and power technology, automation, manufacturing technology, transport technology and logistics, and new materials. The firm also invests in movies, broadcast, television, publisher, music, entertainment, advertising, fashion, design, architecture, multimedia, games, software, and art and culture. It invests in companies based in Berlin. It typically invests between €0.25 million ($0.32 million) and €3 million ($3.83 million) per transaction. The firm prefers to take a board seat in its portfolio companies. IBB Ventures was founded in 1997 and is based in Berlin, Germany.

Show more...

Investment focus

  • Industry: Software, Health Care, Internet
  • Stage:Seed, Series A
  • Geography: Germany, United States, United Kingdom

Investor stats

  • Total investments: 169
  • Round size: Seed $820k–$4.3M; Series A $2.1M–$7M
  • Lead/follow: 16% lead, 84% follow
  • Last fund: Likely still investing — raised $32M in 2022

Portfolio highlights

  • nuwo — Workplace as-a-Service. nuwo is the #1 platform 
for financing, equipping 
and managing hybrid 
workspaces
  • MERSOR — MERSOR is an online marketplace for stylish and pre-curated gifts with a unique and innovative customer experience. We aim to make gifting easy, fast and fun again by not only providing the perfect gift but also assisting the customers in their overall gift management.
  • Wonnda — Wonnda is the digital infrastructure where buyers and suppliers collaboratively build the consumer products of tomorrow
Show all investments...

Oxford Capital
VC Fund · Oxford, Oxfordshire, United Kingdom · 30 investments in Europe Health Care startups

Helping individuals and institutions invest in Venture Capital, Infrastructure and Media companies since 1999.

Show more...

Investment focus

  • Industry: Software, Mobile, Health Care
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, France

Investor stats

  • Total investments: 133
  • Round size: Seed $1.6M–$3.6M; Series A $1.6M–$13M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: May invest from a new fund soon — last raise in 2015

Portfolio highlights

  • Scan.com — Use scan.com to find the best medical imaging centers near you Find an MRI scan, CT scan, X-ray Scan, or other diagnostic imaging scan with scan.com.
  • HelloSelf — The UK's Trusted Online Private Clinical Therapy Service
  • Legislate — Legislate is an easy-to-use contract management platform which provides a suite of customisable contracts for businesses and landlords.
Show all investments...

Newable Private Investing
VC Fund · London, England, United Kingdom · 30 investments in Europe Health Care startups

Newable helps businesses thrive through funding, professional support and premises. Unleashing potential, building resilience & championing growth.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 100
  • Round size: Seed $184k–$2.9M; Series A $1.2M–$3.8M
  • Lead/follow: 23% lead, 77% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Delta g — Delta g Limited is a quantum technology and gravity gradiometry company. A spin-out from the University of Birmingham our technology has applications in industries as varied as civil engineering, infrastructure, defence, rail, navigation and resource exploration. Experts from science, engineering an
  • EarSwitch — Empowering new ways to control and connect with the world through in-ear biometric switch and sensor technology
  • RAB Microfluidics — We diagnose early signs of failure in lubricated machinery and prevent equipment failure using our patented microfluidic technology and AI technology.
Show all investments...

Idinvest Partners
VC Fund · Paris, Ile-de-France, France · 29 investments in Europe Health Care startups

Idinvest Partners is a pan-European private equity manager focused on the low and middle-market segments. With over 6 billion euros under management, the company has developed several complementary areas of expertise, including equity investments in buyout deals focusing on both mid-size as well as young innovative European companies; primaryinvestments in European private equity funds focusing primarily on the middle market segment; secondary investments; mezzanine investments in Europe; and private equity consulting.Idinvest Partners’ recent success stories include Criteo, Clear2Pay, Meetic, Prosensa, Converteam, Kwik Fit, Lastminute.com, Dailymotion, Deezer, Talend, Synthesio, Menlook, Vestiaire Collective, Pretty Simple, Curse.com, Withings, Kantox, Secret Escapes, Happn, Peakon, Dayuse, Botify, Financefox, Azalead and many more.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Series B, Series A
  • Geography: France, United States, Spain

Investor stats

  • Total investments: 217
  • Round size: Series A $3.2M–$15M; Series B $7.4M–$53M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: May invest from a new fund soon — raised $86M in 2021

Portfolio highlights

  • Corti — Corti offers a digital assistant, augmenting medics in improving patient outcomes and internal performance.
  • Coave Therapeutics — Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases.
  • BreezoMeter — BreezoMeter offers personalized air quality & pollen data as well as active fire alerts with worldwide coverage & accuracy down to the street level.
Show all investments...

Atlantic Labs
VC Fund · Berlin, Berlin, Germany · 29 investments in Europe Health Care startups, 12 in the past 12 months

Atlantic Labs supports and invests in mission-driven founders working on transformative technology ventures.&nbsp;<br><br>We partner with founders early, providing the capital, tools and network necessary to growing their companies and accompanying them on their entrepreneurial journey. We are currently active in areas including Digital Health, Future of Work, Machine Learning, Decentralized Networks, Mobility and Industrial Applications.

Show more...

Investment focus

  • Industry: Health Care, Software, Information Technology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Germany, Switzerland, United States

Investor stats

  • Total investments: 156
  • Round size: Seed $1.1M–$5.6M; Pre-Seed $850k–$1.3M; Series A $4.6M–$27M
  • Lead/follow: 43% lead, 57% follow

Portfolio highlights

  • SureIn — small business insurance manager
  • Colonia — Colonia is a logistics company that brings all global trucks and trailers into one shared fleet.
  • Purpose Green — Purpose Green operates as a climatetech company.
Show all investments...

SyndicateRoom
VC Fund · Cambridge, Cambridgeshire, United Kingdom · 28 investments in Europe Health Care startups, 6 in the past 12 months

SyndicateRoom is fintech company made up of data-scientists, investment professionals, software developers and marketers with one mission: to be an early investor in every British startup success story.To do this – and make fund investors money – we don’t try to spot the next Big Thing.Instead, we apply a data-driven model to portfolioconstruction; a repeatable process designed to maximise returns and minimise risk for fund investors. As such, we build startup portfolios that don’t attempt to predict the future; they work to stack the odds in investors’ favour.Our fund, Access EIS, aims to build investors a diversified portfolio of 50+ companies by co‑investing exclusively with some of the UK’s best-performing angel investors.

Show more...

Investment focus

  • Industry: Health Care, Software, Medical
  • Stage:Seed, Equity Crowdfunding
  • Geography: United Kingdom, United States, India

Investor stats

  • Total investments: 109
  • Round size: Seed $240k–$1.8M; Equity Crowdfunding $229k–$1.5M
  • Lead/follow: 10% lead, 90% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Connectd — Online platform underpinned by smart matching technology directly connecting the UK’s leading Founders, Investors & NAMs.
  • Five Alarm Bio — Five Alarm Bio is a drug discovery company. Five Alarm intends to use discoveries to provide secure and efficient remedies for a variety of age-related illnesses and limitations. Five Alarm Bio is creating a small molecule strategy to strengthen the body's defense against aging.
  • Pencil Biosciences — Next Generation Genome Editing Tool
Show all investments...

Cambridge Angels group
VC Fund · Cambridge, Cambridgeshire, United Kingdom · 28 investments in Europe Health Care startups

The Cambridge Angels are a group of high-net worth investors who have proven experience as successful entrepreneurs in internet, software, technology and bio-technology. Members invest in and mentor high quality start-up and early-stage companies in these sectors in the Cambridge (UK) area and throughout the UK.Typical funding requirements thatthe Cambridge Angels meet are in the range of £50,000 to £500,000 - although it is worth noting that several of their portfolio companies have received more than £1m in funding from their Members over several funding rounds.Their Members have been responsible for a large number of the “Cambridge Phenomenon” success stories over recent years. Therefore, in addition to providing funding for early-stage companies, the Cambridge Angels also offer start-ups the considerable benefit of a wide range of expertise, contacts and directly relevant experience in establishing and growing entrepreneurial businesses successfully.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Estonia

Investor stats

  • Total investments: 116
  • Round size: Seed $244k–$2.5M; Series A $983k–$16M
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • Molymem — Molymem enhances the performance of filtering membranes used in separation processes including desalination and the removal of industrial contaminants.
  • Silveray — Silveray develop affordable large-area direct conversion detectors for the X-ray imaging market.
  • Five Alarm Bio — Five Alarm Bio is a drug discovery company. Five Alarm intends to use discoveries to provide secure and efficient remedies for a variety of age-related illnesses and limitations. Five Alarm Bio is creating a small molecule strategy to strengthen the body's defense against aging.
Show all investments...

Speedinvest
VC Fund · Vienna, Wien, Austria · 26 investments in Europe Health Care startups, 53 in the past 12 months

Speedinvest is one of Europe’s most active early-stage investors, with more than €1bn AUM, 40 investors, and offices in Berlin, London, Munich, Paris, Vienna and San Francisco. Your success is our priority, so we don’t just send some money and "check in" at board meetings. Our mission is to empower you with game-changing support throughevery stage of your journey. Our focused investment teams know your industry inside and out. Their Deep Tech, Fintech, Industrial Tech, Network Effects, Digital Health and Subscriptions experience, know-how and deep networks are yours from day one. You also have full access to our in-house Platform+ team of operational experts who can provide tailored growth marketing, people (HR), US business development, and networking support throughout every stage of your journey.

Show more...

Investment focus

  • Industry: Software, FinTech, Financial Services
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Germany, United Kingdom, Austria

Investor stats

  • Total investments: 390
  • Round size: Seed $536k–$6.5M; Pre-Seed $396k–$1.9M; Series A $1.4M–$50M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • autone — Autone is a SaaS operational platform enabling retail & CPG businesses to make optimal decisions easily and quickly
  • Genie — Genie is a productive web development framework in Julia. Build web applications, UIs, backends, integrate with databases, set up web services and APIs.
  • Purpose Green — Purpose Green operates as a climatetech company.
Show all investments...

Business Growth Fund
VC Fund · London, England, United Kingdom · 26 investments in Europe Health Care startups, 28 in the past 12 months

BGF invests in hundreds of businesses from an evergreen balance sheet. But we offer more than just growth capital. Find out what makes us different.

Show more...

Investment focus

  • Industry: Software, Information Technology, Manufacturing
  • Stage:Series A, Private Equity
  • Geography: United Kingdom, Ireland, United States

Investor stats

  • Total investments: 220
  • Round size: Series A $1.2M–$16M; Private Equity $5.4M–$28M
  • Lead/follow: 85% lead, 15% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Avoca Clinic — The Avoca Clinic is Ireland's only plastic surgery clinic. Our World Class Consultants are all Irish Medical Council Registered. Book a free consultation today
  • Stellar Omada — Stellar Omada delivers leading business & digital transformation that exceeds expectations in a constantly changing world. Contact us.
  • Machine Discovery — Machine Discovery is a University of Oxford spin-out commercializing new machine learning technology. We leverage proprietary neural network technology to accelerate expensive calculations — and we do it with minimal data and 99.9% fidelity.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
IP Group
VC Fund · London, England, United Kingdom · 25 investments in Europe Health Care startups, 9 in the past 12 months

IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Therapeutics
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Australia

Investor stats

  • Total investments: 157
  • Round size: Seed $369k–$6.4M; Series A $1.8M–$17M; Series B $7.4M–$61M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: May invest from a new fund soon — last raise in 2014

Portfolio highlights

  • AccelerComm — Our patented, market-leading IP solutions for 4G and 5G are configurable for quick, high-performance implementations across a wide range of applications.
  • Deep Render — Deep Render Ltd. is a spin-out from the Department of Computing at Imperial College London. We are a London based AI start-up that is developing the next generation of media compression algorithms. Our proprietary and patented technology is at the forefront of machine learning research. Furthermore, our Biological Image Compression results arestate-of-the-art, providing at least a 50% efficiency gain over the previous standards
  • Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
Show all investments...

Omnes Capital
VC Fund · Paris, Ile-de-France, France · 24 investments in Europe Health Care startups, 9 in the past 12 months

Omnes, "Powering Entrepreneurs" is a Leading private equity firm dedicated to energy transition and innovation.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Series A, Series B
  • Geography: France, United States, Belgium

Investor stats

  • Total investments: 152
  • Round size: Series A $3.2M–$21M; Series B $4M–$37M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: May invest from a new fund soon — raised $407M in 2020

Portfolio highlights

  • Iktos — Iktos is the only company to offer generative modeling with built-in synthetic accessibility for successful drug discovery
  • DiogenX — We incorporated DiogenX with the objective to provide new therapeutic solutions for diabetic patients. With Patrick Collombat and the team, we are focused on developing a first-in-class regenerative treatment for type 1 diabetes. Benjamin Charles CEO See the team News See more Our Work OUR APPROACH ABOUT DIABETES
  • The Exploration Company — For Space & Non-Space Industries.
Show all investments...

GO CAPITAL
VC Fund · Rennes, Bretagne, France · 24 investments in Europe Health Care startups, 8 in the past 12 months

GO CAPITAL is a management company approved by the AMF and a member of AFIC. It is based in Rennes, and manages more than 130 million of assets by investing primarily in western France in innovative companies with high growth potential.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Seed, Series A
  • Geography: France, Canada, Israel

Investor stats

  • Total investments: 104
  • Round size: Seed $504k–$4.2M; Series A $1.7M–$6.4M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Abcely — Abcely is a biotech firm that is working on a novel anti-cancer medication.
  • Episto — Episto helps you collect ultra-authentic insights from your targets, anywhere in the world, simply and instantly
  • Kanta — Kanta provides an anti-money laundering technology that automates data gathering and processing operations while maintaining standard compliance. Kanta automates time-consuming activities and manages AML regulatory monitoring.
Show all investments...

Nina Capital
VC Fund · Barcelona, Catalonia, Spain · 24 investments in Europe Health Care startups, 15 in the past 12 months

We deploy early stage capital to fuel the growth of need-driven health technology companies.

Show more...

Investment focus

  • Industry: Health Care, Artificial Intelligence, Medical
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, Austria

Investor stats

  • Total investments: 58
  • Round size: Seed $1.2M–$6M; Pre-Seed $573k–$964k; Series A $5M–$21M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • basys.ai — Basys.ai automates the process of prior authorization and utilization management to improve costs and timeliness for health plans/payers using an AI-based platform. The proprietary platform automates the process of encoding/digitizing the payer policies using machine learning, thus reducing the piloting timeline by up to 9 months.
  • Lillian Care — Lillian is building a nationwide network of health facilities in Germany.
  • ALFIE — AI software platform that provides consistent and automated measurements from radiographic images used to assess spinal disorders.
Show all investments...

GM&C Life Sciences Fund
VC Fund · Alderley Edge, Cheshire, United Kingdom · 24 investments in Europe Health Care startups

The GM&C Life Sciences Fund is a seed and early stage venture capital fund targeting life sciences businesses located in the Greater Manchester and Cheshire & Warrington region. The Fund is managed by Catapult Venture Managers ("Catapult Ventures").The Fund is based at Alderley Park, which is well recognised as a site ofnational importance, being the largest life sciences campus of its kind in the UK with more than 500,000 sq. ft. of top-end laboratory and related space and facilities. Until recently, the Park was the R&D headquarters for AstraZeneca.Since 2002, Catapult Ventures has backed a significant number of companies across a broad range of life sciences, including therapeutics (such as Abzena and Oxford BioTherapeutics), medical devices (such as Monica Healthcare and Probe Scientific), contract research organisations (such as R5 Pharmaceuticals and FDAS), diagnostics developers (such as Lumora and Biofortuna), as well as developers of technology used in healthcare applications (such as Oxford Cryosystems and Accutronics). The Fund is the result of a collaboration between Cheshire and Warrington Enterprise Partnership, Greater Manchester Combined Authority, Cheshire East Council, and Manchester Science Partnerships.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: United Kingdom, Italy, Germany

Investor stats

  • Total investments: 32
  • Round size: Seed $61k–$903k
  • Lead/follow: 69% lead, 31% follow

Portfolio highlights

  • ScubaTx — ScubaTx is a breakthrough organ preservation device organ transplant. The ScubaTx device will leverage world-leading expertise in software design to commercialise a proven but unexploited organ preservation technique, Persufflation. ScubaTx will offer healthcare providers significant net savings, an
  • Flynotes — Flynotes is a digital software platform helping dentists deliver personalised patient care
  • QV Bioelectronics — Manchester-based start-up QV Bioelectronics is developing innovative electrotherapy devices for the treatment of certain types of brain tumours.
Show all investments...

Sciety
VC Fund · Stockholm, Stockholms Lan, Sweden · 24 investments in Europe Health Care startups

Whether you are an investor seeking impactful returns or an entrepreneur looking to take your business to the next level, Sciety is your go-to partner. Join Sciety Venture Partners to invest in the most promising life science companies in the Nordics or get in touch to learn how we can help to turn your life science or health tech innovation into a thriving business.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Pharmaceutical
  • Stage:Seed, Series A
  • Geography: Sweden, Ukraine

Investor stats

  • Total investments: 33
  • Round size: Seed $125k–$2.3M; Series A $429k–$6.1M
  • Lead/follow: 94% lead, 6% follow

Portfolio highlights

  • Encare — Encare was established in 2009 to implement the ERAS Protocols on a global basis by- providing training to health care professionals on the ERAS Protocols- providing an interactive and web-based information system for evidence based - best practice management (EBM)The company has developed an interactive, user-friendly interface forthe collection, documentation and follow-up on critical performance and quality parameters as lined out by leading clinical experts in respective protocol[1] based on, at any time, best practice and evidence.The data collected in the web-based solution is interactive and offers immediate feedback of performance, which will generate significant and sustainable improvement of efficiency and quality of care as well as generate substantial health care savings.Encare has the rights to commercialize surgical protocols developed by the ERAS Society. The company has so far rolled out the audit system to more than 120 hospitals in Canada, France, Norway, Poland, Sweden, South Africa, Switzerland, the United Kingdom, Argentina, Mexico, Colombia, Brazil, Singapore and the United States.The ERAS Society was formed in 2001 with the aim to establish evidence based protocols as best practice standards in perioperative care. ERAS Society has published a wide range of publications regarding protocols and guidelines for enhanced recovery after surgery.
  • PharmNovo — Latest News from PharmNovo. Learn more about pain, neuropathic pain, chronic pain. Treatment with our lead candidate PN6047. Therapy market, our networks. There is a huge unmet medical need for people suffering from chronic pain.
  • Capitainer — Quantitative microsampling solutions for diagnostics, research and clinical trials. Microsampling you can trust.
Show all investments...

24 Haymarket
VC Fund · London, England, United Kingdom · 23 investments in Europe Health Care startups, 6 in the past 12 months

24Haymarket is an investment network which included several highly-experienced private equity and venture capital investors, seasoned entrepreneurs, and senior operators. Investing up to £5 million in growth companies in the UK and Europe. They invested their own capital in direct alignment with entrepreneurs and actively support their growthagenda and join the board of the companies in which they invest. Since inception in 2011, 24Haymarket has invested in more than 50 high-growth businesses.

Show more...

Investment focus

  • Industry: Health Care, Software, Information Technology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 95
  • Round size: Seed $1.2M–$3.7M; Series A $1.5M–$16M
  • Lead/follow: 42% lead, 58% follow

Portfolio highlights

  • myGwork — The global recruitment & networking hub for LGBTQ+ professionals. Find jobs in lesbian, gay, bisexual and transgender friendly organisations. Grow your LGBTQ+ professional network. Read the latest LGBTQ+ professional news.
  • Previsico — Previsico is a spinOut company from Loughborough University specialising in modelling flooding in real-time, using weather predictions to make street-level flood nowcasts and forecasts. The company's mission is to be the leading global provider of cutting-edge flood prediction that saves lives and livelihoods.Its FloodMap Live producesround the clock street-level flood risk predictions and analytics. Uniquely, these are continuously modelled and updated using a combination of different weather forecasts. This allows the company to map the likelihood of short and long-term surface water events in real-time to the street level.
  • Huq Industries — The leading monitoring platform for footfall, dwell, catchment and traffic flows valued by government, retail and real-estate. Used by 50+ councils!
Show all investments...

Kelvin Capital
VC Fund · Glasgow, Glasgow City, United Kingdom · 23 investments in Europe Health Care startups

We invest venture capital in to globally ambitious companies which have the potential to deliver a significant return to our investors

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Manufacturing
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 72
  • Round size: Seed $139k–$1.1M; Series A $1.6M–$24M
  • Lead/follow: 49% lead, 51% follow

Portfolio highlights

  • novosound — Novosound is an award winning Scottish sensors company utilising thin-film processes to eliminate conventional limitations in ultrasound sensors.
  • Snappy Shopper — Order your favourite products from your local convenience store, for delivery from as little as 30 minutes with Snappy Shopper. Your every day essentials are only a click away - order your grocery delivery online or through our app.
  • Sofant Technologies — Sofant is developing a low cost RF MEMS technology that solves power consumption and heat problems in high frequency phased array antenna systems.
Show all investments...

Boehringer Ingelheim Venture Fund
VC Fund · Ingelheim Am Rhein, Rheinland-Pfalz, Germany · 23 investments in Europe Health Care startups

The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, Germany, Belgium

Investor stats

  • Total investments: 82
  • Round size: Seed $1.3M–$14M; Series A $3.8M–$29M; Series B $11M–$50M
  • Lead/follow: 49% lead, 51% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • DiogenX — We incorporated DiogenX with the objective to provide new therapeutic solutions for diabetic patients. With Patrick Collombat and the team, we are focused on developing a first-in-class regenerative treatment for type 1 diabetes. Benjamin Charles CEO See the team News See more Our Work OUR APPROACH ABOUT DIABETES
  • smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
  • Rewind Therapeutics — Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.The company's first-in-class remyelinating therapeutics block inhibitory signals that prevent the expansion and migration of oligodendrocyte stem cells in order to promote effective remyelination, enabling medicalpractitioners to treat patients suffering from multiple sclerosis and other myelin-related diseases with efficacy.
Show all investments...

Octopus Ventures
VC Fund · London, England, United Kingdom · 22 investments in Europe Health Care startups, 36 in the past 12 months

We provide venture capital investment for the people, ideas and industries that will change the world. Learn about what we do and the kind of founders we back.

Show more...

Investment focus

  • Industry: Software, Health Care, FinTech
  • Stage:Series A, Seed, Series B
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 273
  • Round size: Seed $1.2M–$6.1M; Series A $2.5M–$15M; Series B $5.9M–$45M
  • Lead/follow: 59% lead, 41% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Automata — Automata is a deep-tech company that creates products that empower people to automate physical work. The company's product, Eva, is a lightweight and affordable robot arm built for professionals in a production line, in a lab, a home workshop or even in a classroom. People don't need to be technical experts to communicate with robots. Theweb-based software platform can be programmed by anyone, anywhere, any time, from any device, making it easy to reconfigure for a wide range of different tasks.Automata was founded on 2015 and is headquartered in London, England.
  • Awell Health — Ollie is a vast library of over 100 interface blocks with complete Webflow CMS integration. Build beautiful websites in less time than ever.
  • Pencil Biosciences — Next Generation Genome Editing Tool
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Auriga Partners
VC Fund · Paris, Ile-de-France, France · 22 investments in Europe Health Care startups

Since 1998, AURIGA PARTNERS, an independent Venture Capital firm, has been managing several early stage funds specializing in Information Technology and Life Sciences.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A
  • Geography: France, United States, Switzerland

Investor stats

  • Total investments: 126
  • Round size: Series A $2.1M–$14M; Series B $3.8M–$31M
  • Lead/follow: 17% lead, 83% follow
  • Last fund: May invest from a new fund soon — raised $45M in 2013

Portfolio highlights

  • Patrowl — Identify and harden your External Security Posture with the leader. Let us manage time-consuming tasks and focus on remediation
  • Exeliom — Exeliom is a clinical-stage biopharmaceutical company tackling the use of commensal bacteria as drugs. Their mission is to harness the therapeutic potential of gut microbiota to enable people to lead longer and healthier lives. They are committed to developing the next generation of probiotics: innovative microbial therapies.Exeliom develops anew class of medicines called Live Biotherapeutics based on their growing understanding of the central role of the microbiota in the immune system.The company was founded in 2016 and is headquartered in Dijon, France.
  • Vade Secure — Vade is a global leader in predictive email defense, protecting 1 billion inboxes worldwide. AI-based email security for Microsoft 365.
Show all investments...

Bayern Kapital
VC Fund · Landshut, Bayern, Germany · 22 investments in Europe Health Care startups, 21 in the past 12 months

Bayern Kapital (founded at the end of 1995) is a wholly owned subsidiary of the LfA Foerderbank Bayern (Bavaria‘s development bank). Bayern Kapital’s objective is to finance research and development as well as the market launch of new products, product diversifications, and expansion of the market share.The requesting company has to be located inBavaria. Industries are e. g. IT/software, life sciences, new materials, micro-systems and environmental technologies.Bayern Kapital and its funds have invested in more than 250 companies and currently manages funds to the value of EUR 340 m. The five investing funds currently managed by Bayern Kapital are Seedfonds Bayern, Clusterfonds Start-Up!, Innovationsfonds, Innovationsfonds EFRE and Wachstumsfonds Bayern.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series A
  • Geography: Germany, United States, Finland

Investor stats

  • Total investments: 152
  • Round size: Seed $750k–$4.6M; Series A $1.5M–$16M
  • Lead/follow: 14% lead, 86% follow
  • Last fund: May invest from a new fund soon — last raise in 2010

Portfolio highlights

  • EGYM — EGYM makes the gym work for everyone. They provide gym operators, trainers and members with the technology to advance the user experience and thus make gyms more profitable. There is their own EGYM cloud where they connect all hardware on the training floor (supplier independent) into one cloud and they provide trainers and members via theirTrainer App and Member App access to that data. As the strength area is typically purely mechanical they have even developed their own smart strength machines-connected to their cloud as well.
  • sewts — Founded in 2019 and based in Munich, sewts GmbH provides cutting-edge perception software, pushing the boundaries of robotics in processing of easily deformable materials. sewts has developed and demonstrated a unique technology that uses high-precision finite element method (FEM) simulations to efficiently train machine learning algorithms. Theintelligent software solution enables countless applications in industrial automation like the handling of textiles in industrial laundries or the manufacturing of garment. sewts is backed by APEX Ventures, Bayern Kapital, High-Tech Gründerfonds, UnternehmerTUM Initiative for Industrial Innovators and a couple of highly experienced business angels.
  • ChargeX — ChargeX provides electric car charging solutions. Tobias Wagner, Michael Masnitza, and Johannes Engeln founded it in 2017, with its headquarters in Munich in Germany.
Show all investments...

Think.Health
VC Fund · Fürstenfeldbruck, Bayern, Germany · 22 investments in Europe Health Care startups

Think.Health invests as a boutique risk-taker in healthcare ventures. We continuously seek innovations and disruptive business models in digital healthcare, medical technologies and health service providers,

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Seed, Series A, Series B
  • Geography: Germany, United States, Switzerland

Investor stats

  • Total investments: 31
  • Round size: Seed $1.1M–$8.3M; Series A $3.5M–$19M
  • Lead/follow: 32% lead, 68% follow

Portfolio highlights

  • Vara — Vara develops a breast cancer screening platform powered by AI for radiologists, allowing them to focus on finding cancer early. While we provide. Vara also provides remote mammography reading services to those that lack the radiologists. Vara's mission is to make affordable diagnostics available all over the world by designing machinelearning-powered workflows that users love to work with.
  • anvajo — Originally started at TU Dresden, anvajo can now look back on several years of innovative research and successful product development with uninterrupted growth. As part of the business expansion and ongoing team building, anvajo moved into its new headquarters in Dresden in January 2020. On 1300 m² practically all areas, including development,production and support functions are united under one roof.
  • Navignostics — Our mission is to identify the ideal treatment to battle each cancer patient’s disease and reduce suffering throughout their journey.At Navignostics we characterize tumors using spatial single-cell proteomics. We use our unique capabilities to identify a cancer treatment that will optimally fight each patient’s tumor. We also accelerate cancerdrug development by providing key insights into drug mechanisms and tumor features for companion diagnostic development.Our highly robust and reliable technology and our leading data analytics position us ideally to enable precision cancer diagnostics for patients and to provide services to pharma and biotech partners.This way we help people suffering from cancer by making more drugs available and by finding the right one for every patient.
Show all investments...

Kernel Capital
VC Fund · Cork, Cork, Ireland · 22 investments in Europe Health Care startups

Kernel Capital is the independent manager of The Bank of Ireland Kernel Capital Venture Funds, one of the largest and most active sources of equity finance on the island of Ireland. Kernel leverage their extensive network to enable their portfolio companies recruit the highest caliber people, to break into new international markets and to generaterevenues of scale. It is the only investment firm with venture capital Funds dedicated to both jurisdictions on the Island. Kernel have raised over €210M from investors which including their strategic partner Bank of Ireland, Invest NI, Enterprise Ireland, Galway University Foundation, The University of Limerick Foundation, The New York State Common Retirement Fund and undisclosed Family Offices. Consistently delivering strong financial returns for their investors Kernel have led more than 20 substantial trade sales to NASDAQ, NYSE, and LSE listed corporations.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series A
  • Geography: Ireland, United Kingdom, France

Investor stats

  • Total investments: 86
  • Round size: Seed $536k–$4.3M; Series A $1.4M–$9M
  • Lead/follow: 50% lead, 50% follow
  • Last fund: May invest from a new fund soon — last raise in 2013

Portfolio highlights

  • Pretto — Pretto is the only truly transparent online real estate price comparator.Pretto accompanies you until the signing of your loan, free of charge and without commitment.
  • Pilot Photonics — Welcome to Pilot Photonics, a laser product development company in Dublin, Ireland. We provide optical frequency combs and tunable lasers.
  • Causeway Sensors — The Affinity, is a compact, bench-top Biosensor providing accurate real-time analysis at an accessible price. The Affinity biosensor and accompanying Access Chip incorporate the latest advancements in Nanotechnology, providing the biochemistry researcher the perfect platform to explore the complex world of biomolecular interactions.
Show all investments...

Archangels
VC Fund · Edinburgh, Edinburgh, City of, United Kingdom · 22 investments in Europe Health Care startups, 6 in the past 12 months

Established in 1992. Archangels is the oldest continuously operating business angel syndicate in the World. Investing in IP-rich tech & life sciences companies in Scotland, UK.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 72
  • Round size: Seed $123k–$2.7M; Series A $1.5M–$7M
  • Lead/follow: 54% lead, 46% follow

Portfolio highlights

  • Bio-Images Drug Delivery — BDD Pharma combine drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and new innovative pharmaceutical products. Rapid parallel clinical testing with SWIFT significantly reduces time from product concept to clinical success.
  • Cytomos — Cytomos develops and provides integrated, predictive analytics systems for intelligent bioprocessing in biopharma and cell therapy domains.
  • Administrate — Manage 100% of enterprise training operations with configurable training management software, designed to scale with your organization.
Show all investments...

Meusinvest (Noshaq)
VC Fund · Liège, Liege, Belgium · 22 investments in Europe Health Care startups, 10 in the past 12 months

Noshaq offers financial services to help businesses develop.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: Belgium, France, Germany

Investor stats

  • Total investments: 54
  • Round size: Seed $134k–$4M; Series A $1.1M–$15M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • Axithra — Saving lives and improving health economics through significant advancement of therapeutic drug monitoring (TDM).
  • RISORCE — RISORCE fills a need in Belgium for local solutions for processing tire waste while remaining dedicated to a circular economy strategy. We provide a regionally-based, technologically and environmentally sound solution.
  • Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Show all investments...

Portugal Ventures
VC Fund · Porto, Lisboa, Portugal · 22 investments in Europe Health Care startups, 13 in the past 12 months

Portugal Ventures is a venture capital firm that is part of the Banco Português de Fomento group, currently manages 170 million euros and has more than 130 portfolio companies. It invests in startups in the pre-seed, seed and series A stages that offer innovative solutions for the international market in the digital, engineering&industry, lifesciences, and tourism sectors. Since 2012, Portugal ventures has invested 164 million euros in 147 new businesses.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Seed, Pre-Seed
  • Geography: Portugal, United States, France

Investor stats

  • Total investments: 159
  • Round size: Seed $107k–$1.6M; Pre-Seed $107k–$643k
  • Lead/follow: 6% lead, 94% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • HiJiffy — Increase direct bookings and upselling with HiJiffy's AI-powered communication solutions for hospitality.
  • MyCareforce — The platform that connects nurses to available shifts.
  • Floating Particle — Floating Particle is a technology and innovation company that drives an innovative solution for waste management and clean energy. Floating Particle specializes in IoT, Big Data and Machine Learning to provide cutting-edge technology to the customers.
Show all investments...

M Ventures
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 22 investments in Europe Health Care startups, 17 in the past 12 months

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, Switzerland, United Kingdom

Investor stats

  • Total investments: 118
  • Round size: Seed $2.1M–$18M; Series A $6M–$42M; Series B $9.5M–$67M
  • Lead/follow: 39% lead, 61% follow

Portfolio highlights

  • BeeOLED — BeeOLED’s technology enables OLED displays with significantly improved efficiency, brightness and operational stability at lower overall costs due to a less complex device structure.
  • Celestial AI — We develop audacious AI computing platforms that elevate performance, energy and economic efficiencies, enabling our customers to rapidly deploy innovations in their AI applications.
  • Lightcast Discovery — Flexible control over droplet number, occupancy, location and movement. Enabling efficient, multi-step workflows with unprecedented flexibility.
Show all investments...

Northstar Ventures
VC Fund · Newcastle Upon Tyne, Newcastle upon Tyne, United Kingdom · 22 investments in Europe Health Care startups

Northstar Ventures is a venture capital firm investing in innovative solutions to help solve the most pressing societal issues we have today.  Our ticket sizes range from £100k to £500k into early stage tech companies. We provide added value in leveraging our network of university partners, funders, non-executive directors and talent to supporteach investment.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Internet
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Estonia

Investor stats

  • Total investments: 153
  • Round size: Seed $37k–$1.2M; Series A $276k–$8.8M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • IOTech — Discover IOTech Systems, the open edge data platform for developing, deploying, and managing Industrial Edge applications at scale. Find out more here.
  • MarraBio — MarraBio Ltd. is a spin out company from Newcastle University using engineered bacterial protein polymers to provide bioactivity to cells at the industrial scale in the cultivated meat sector and beyond.
  • Peek Home — Peek Home provides sketch plans, prices and planning advice for people who are puzzled by the process of creating their perfect home. All we need is your house number & postcode - no home visit needed.
Show all investments...

Epidarex Capital
VC Fund · Bethesda, Maryland, United States · 21 investments in Europe Health Care startups

Epidarex Capital invests in early-stage, high growth life science and health technology companies in under-ventured markets. Its international team is led by Sinclair Dunlop, Kyp Sirinakis and Liz Roper. With offices in the United States and United Kingdom Epidarex Capital’s investors represent a cross-section of leading universities, internationalcorporations, development agencies and financial institutions. Epidarex was created to meet the need for more sector-specific financial backing for young companies, including spin-outs from leading research universities.

Show more...

Investment focus

  • Industry: Biotechnology, Therapeutics, Health Care
  • Stage:Series A, Seed, Series B
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 39
  • Round size: Seed $536k–$8M; Series A $2M–$24M; Series B $2.4M–$38M
  • Lead/follow: 56% lead, 44% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Nyra Medical — MitraPlug has created a catheter-plug technology for repairing a leaky mitral valve in the heart.This adjustable device needs only a two-inch surgical incision and can be inserted directly into the heart. Then the cardiologist can use the catheter to adjust the size and position of the plug to correct the leakage. When correctly fitted, thecatheter is removed, and the incision is closed, leaving only a small scar.
  • RapidPulse — RapidPulse, Inc. is a privately held medical device company that develops minimally invasive vascular products for ischemic stroke. The company is advancing the development of the RapidPulse™ Cyclic Aspiration System, which includes a novel aspiration pump to allow rapid and consistent removal of blood clots from the brain. RapidPulse is a spinoutof Syntheon LLC., a medical device incubator dedicated to developing innovative products in the medical device industry
  • Transine Therapeutics — Transine Therapeutics is a private biotechnology company focused on the development of a novel class of therapeutic RNAs that can upregulate protein expression with an unprecedented level of control and specificity: the SINEUPs®. The company's pioneering technology is expected to offer an entirely unique mechanism of action for currentlyhard-to-treat diseases by massively extending the druggable proteome and allowing it to address diseases that have been beyond the reach of small molecules, conventional biologics, or gene therapies.
Show all investments...

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Health Care VC Funds in Europe investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 48,091 VC funds investing in Europe Health Care startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists